Bausch Health settles generic dispute with Actavis

13-09-2018

Bausch Health settles generic dispute with Actavis

Natee Meepian / iStockphoto.com

Canada-based Bausch Health has agreed to settle all IP litigation with Actavis over antibiotic drug Xifaxan (rifaximin).


Bausch Health, Actavis, Teva, Xifaxan, generics, licence, ANDA, settlement, patent infringement, patent settlement

LSIPR